Drug Type Targeted protein degraders |
Synonyms- |
Target |
Action inhibitors |
Mechanism PIP4K2C inhibitors(phosphatidylinositol-5-phosphate 4-kinase type 2 gamma inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | United States | 09 Apr 2024 |